Microbial components, such as lipopolysaccharides, augment immune responses by activating Toll-like receptors (TLRs). Some have interpreted this to mean that TLR signalling might not only help to initiate the adaptive immune response, but may also be required for it 1 . The expanded view is shared by Pasare and Medzhitov 2 , who conclude from an analysis of mice deficient in MyD88 (a TLR-signalling adaptor protein) that the generation of Tdependent antigen-specific antibody responses requires activation of TLRs in B cells. However, we show here that robust antibody responses can be elicited even in the absence of TLR signals. This appreciable TLR-independence of immune responses should be taken into account in the rational design of immunogenic and toleragenic vaccines.
In mice that lack both MyD88 and TRIF (another TLR-signalling adaptor protein), all known types of TLR signalling are absent 3 . We find that preimmune serum immunoglobulin concentrations are substantial in these mice, and that T-cell-dependent antibody responses to an antigen administered in alum are unimpaired (Fig. 1) . It is notable that immunization with an antigen in alum, one of the few adjuvants approved for human use, promotes a TLR-independent antibody response. Further, we find that MyD88/TRIF double-deficient mice generate a robust antibody response to the T-independent antigen trinitrophenolFicoll (results not shown).
In the final analysis, we believe that Pasare and Medzhitov have simply demonstrated that TLR-dependent B-cell responses depend upon TLR signalling. But TLR signalling is clearly not essential for a response to typical vaccination. are TLR-independent. But in any event, our main discovery was that TLR signalling has to happen in B cells in order for the optimum Tcell-dependent antibody response to be generated. It was not, as claimed by Nemazee et al. 
